Serum soluble urokinase plasminogen activator receptor and early stage of diabetic kidney disease in patients with type 2 diabetes

被引：0
|
作者：
Wang, Tao [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Nanjing, Jiangsu, Peoples R China
来源：
DIABETES-METABOLISM RESEARCH AND REVIEWS | 2018年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
961969
引用
收藏
页数：2
相关论文
共 50 条
  • [1] SERUM SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH DIABETIC KIDNEY DISEASE
    Lupusoru, Gabriela Elena
    Ailincai, Ioana-Georgiana
    Sorohan, Bogdan Marian
    Andronesi, Andreea Gabriella
    Lupusoru, Mircea
    Andronesi, Danut
    Manda, Dana
    Caragheorgheopol, Andra
    Ismail, Gener
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 : 378 - 378
  • [2] Expression of Urokinase-type Plasminogen Activator Receptor and its Soluble Form in Type 2 Diabetic Kidney Disease
    Zhou, Yujing
    Ren, Jianmin
    Li, Peng
    Ma, Rong
    Zhou, Mengkun
    Zhang, Ningxin
    Kong, Xiangguo
    Hu, Zhao
    Xiao, Xiaoyan
    ARCHIVES OF MEDICAL RESEARCH, 2019, 50 (05) : 249 - 256
  • [3] Serum levels of soluble urokinase plasminogen activator receptor in Japanese patients with chronic kidney disease
    Taniguchi, Yoshinori
    Shimamura, Yoshiko
    Horino, Taro
    Fujimoto, Shimpei
    Terada, Yoshio
    KIDNEY INTERNATIONAL, 2014, 86 (01) : 209 - 210
  • [4] SOLUBLE UROKINASE TYPE PLASMINOGEN ACTIVATOR RECEPTOR AS A PREDICTOR OF CHRONIC KIDNEY DISEASE
    Ferreira, Ana Carina
    Verdelho, Miguel
    Santos, Maria Ceu
    Nolasco, Fernando
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 165 - 165
  • [5] Soluble urokinase plasminogen activator receptor is elevated in diabetes and associated with diabetic complications in patients with type 1 diabetes
    Theilade, S.
    Lyngbaek, S.
    Hansen, T. W.
    Eugen-Olsen, J.
    Fenger, M.
    Rossing, P.
    Jeppesen, J.
    DIABETOLOGIA, 2014, 57 : S508 - S508
  • [6] Serum levels of soluble urokinase plasminogen activator receptor in Japanese patients with chronic kidney disease Reply
    Wada, Takehiko
    Nangaku, Masaomi
    Maruyama, Shoichi
    Matsuo, Seiichi
    KIDNEY INTERNATIONAL, 2014, 86 (01) : 210 - 210
  • [7] Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney disease
    Lv, Li
    Wang, Fang
    Wu, Liang
    Wang, Jin-Wei
    Cui, Zhao
    Hayek, Salim S.
    Wei, Changli
    Reiser, Jochen
    He, Kevin
    Zhang, Luxia
    Chen, Min
    Zhao, Ming-Hui
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (03) : 465 - 470
  • [8] SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) IS ASSOCIATED WITH KDIGO CHRONIC KIDNEY DISEASE STAGE IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE
    Yussef, Sarah Mohammed
    Ursli, Martin
    Rothschild, Inke
    Faraj-Allah, Ayah
    Koppensteiner, Renate
    Schernthaner, Gerit-Holger
    Hoebaus, Clemens
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 161 - 161
  • [9] Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis
    Drechsler, Christiane
    Hayek, Salim S.
    Wei, Changli
    Sever, Sanja
    Genser, Bernd
    Krane, Vera
    Meinitzer, Andreas
    Marz, Winfried
    Wanner, Christoph
    Reiser, Jochen
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (08): : 1265 - 1273
  • [10] Measurement of soluble urokinase plasminogen activator receptor in serum
    Riisbro, R
    Piironen, T
    Brünner, N
    Larsen, B
    Nielsen, HJ
    Stephens, RW
    Hoyer-Hansen, G
    JOURNAL OF CLINICAL LIGAND ASSAY, 2002, 25 (01): : 53 - 56
12345